Хайлтын үр дүнгүүд - Carlo Gambacorti‐Passerini
- 92-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples -н Daniele Ramazzotti, Fabrizio Angaroni, Davide Maspero, Carlo Gambacorti‐Passerini, Marco Antoniotti, Alex Graudenzi, Rocco Piazza
Хэвлэсэн 2021Artigo -
11
Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK–Positive Anaplastic Large Cell Lymphoma -н Monica Ceccon, Luca Mologni, Giovanni De Giudici, Rocco Piazza, Alessandra Pirola, Diletta Fontana, Carlo Gambacorti‐Passerini
Хэвлэсэн 2014Artigo -
12
-
13
-
14
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option -н Jeffrey H. Lipton, Tim H. Brümmendorf, Carlo Gambacorti‐Passerini, Valentín García‐Gutiérrez, Michael W. Deininger, Jorge E. Cortés
Хэвлэсэн 2022Revisão -
15
hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis -н Angela Iervolino, Giorgia Santilli, Rossana Trotta, Clara Guerzoni, Vincenzo Cesi, Anna Bergamaschi, Carlo Gambacorti‐Passerini, Bruno Calabretta, Danilo Perrotti
Хэвлэсэн 2002Artigo -
16
ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1–restricted CD8+ T-cell epitopes -н Lorena Passoni, Antonio Scardino, C Bertazzoli, Barbara Gallo, Addolorata M. L. Coluccia, François A. Lemonnier, Konstadinos Kosmatopoulos, Carlo Gambacorti‐Passerini
Хэвлэсэн 2002Artigo -
17
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review -н Jorge E. Cortés, Jane F. Apperley, Daniel J. DeAngelo, Michael W. Deininger, Vamsi Kota, Philippe Rousselot, Carlo Gambacorti‐Passerini
Хэвлэсэн 2018Revisão -
18
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes -н Rocco Piazza, Daniele Ramazzotti, Roberta Spinelli, Alessandra Pirola, De Luca, Pierangelo Ferrari, Vera Magistroni, Nicoletta Cordani, Nitesh Sharma, Carlo Gambacorti‐Passerini
Хэвлэсэн 2017Artigo -
19
-
20
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation -н Addolorata Maria Luce Coluccia, Angelo Vacca, Mireia Duñach, Luca Mologni, Sara Redaelli, Victor Bustos, Daniela Benati, Lorenzo A. Pinna, Carlo Gambacorti‐Passerini
Хэвлэсэн 2007Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Biology
Myeloid leukemia
Cancer research
Oncology
Imatinib
Gene
Genetics
Immunology
Cancer
Gastroenterology
Adverse effect
Bosutinib
Nilotinib
Dasatinib
Anaplastic lymphoma kinase
Malignant pleural effusion
Tyrosine kinase
Leukemia
Tyrosine-kinase inhibitor
Biochemistry
Cell biology
Lymphoma
Receptor
Lung cancer
Chromosomal translocation
ALK inhibitor
Crizotinib
Philadelphia chromosome